Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30

Bone Marrow Transplantation volume 47, pages 473–482 (2012)Cite this article

Abstract

The EORTC Quality of Life Core Questionnaire QLQ-C30 is widely used, but no reference values are available for patients receiving HSCT. We retrieved data for 38 samples from 33 papers in English and German that provided evaluable information on QLQ-C30 scores (mean, s.d.) covering about 2800 patients. Results are presented as a table that provides reference data that allow QLQ-C30 scores at different points during the disease trajectory to be put in context. With respect to their central tendency and their variance, scores vary over time. Quality of life is lowest during inpatient time. About 1 year after HSCT, the pre-transplant level is reached. Physical functioning is the scale reaching the highest level of all scales. Fatigue, dyspnoea and insomnia are symptoms that remain at an elevated level and should thus be considered as persisting problems after HSCT. For the interpretation of differences between scores, a very conservative recommendation would be to set the s.d. at 30 points. Doing so, one could be quite sure of having found a clinically significant change if the difference of two scores exceeds 15 points. Differences below 5 points should be interpreted with caution.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Aaronson NK, Ahmedzai S, Bergmann B, Bullinger M, Cull A, Duez NJ et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international trials in oncology. J Natl Cancer Inst 1993; 85: 365–376.

    Article  CAS  PubMed  Google Scholar 

  2. Efficace F, Bottomley A, Coens C . Which is the most frequently used health-related quality of life (HRQOL) measure in cancer clinical trials? (abstract). Psychooncology 2006; 15 (2 (Suppl)): S135–S136.

    Google Scholar 

  3. Küchler T, Behrend M . Der onkologische Patient—Lebensqualität und supportive Therapie. Im Focus Onkologie 2001; 4: 49–52.

    Google Scholar 

  4. Fayers P, Bottomley A . Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer 2002; 38 (Suppl 4): S125–S133.

    Article  PubMed  Google Scholar 

  5. Velikova G, Weis J, Hjermstad MJ, Kopp M, Morris P, Watson M et al. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. Eur J Cancer 2007; 43: 87–94.

    Article  CAS  PubMed  Google Scholar 

  6. Fayers PM, Aaronson NK, Bjordal K, Curran D, Groenvold N . The EORTC QLQ-C30 Scoring Manual. 2 edn. European Organization for Research and Treatment of Cancer: Brussels, Belgium, 1999.

    Google Scholar 

  7. Sloan JA, Frost MH, Berzon R, Dueck A, Guyatt G, Moinpour C et al. The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer 2006; 14: 988–998.

    Article  PubMed  Google Scholar 

  8. Klee M, Groenvold M, Machin D . Quality of life of Danish women: population-based norms for the EORTC QLQ-C30. Qual Life Res 1997; 6: 27–34.

    Article  CAS  PubMed  Google Scholar 

  9. Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S . Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=30 (+3). J Clin Oncol 1998; 16: 1188–1196.

    Article  CAS  PubMed  Google Scholar 

  10. Michelson H, Bolund C, Nilsson B, Brandberg Y . Health-related quality of life measured by the EORTC QLQ-C30: reference values from a large sample of the Swedish population. Acta Oncol 2000; 39: 477–484.

    Article  CAS  PubMed  Google Scholar 

  11. Schwarz R, Hinz A . Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37: 1345–1351.

    Article  CAS  PubMed  Google Scholar 

  12. Fayers PM . Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer 2001; 37: 1331–1334.

    Article  CAS  PubMed  Google Scholar 

  13. Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 2008; 42: 819–827.

    Article  CAS  PubMed  Google Scholar 

  14. Hendriks MGJ, Schouten HC . Quality of life after stem cell transplantation: a patient, partner and physician perspective. Eur J Int Med 2002; 13: 52–56.

    Article  Google Scholar 

  15. Goodman KA, Riedel E, Serrano V, Gulati S, Moskowitz C, Yahalom J . 2584: Health-related quality of life in long-term survivors of autologous hematopoietic-cell transplantation for refractory and relapsed Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2006; 66 (3, Supplement 1) S534–S535 (abstract 2584).

    Article  Google Scholar 

  16. Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Gundy C et al. EORTC QLQ-C30 Reference Values (online: http://groups.eortc.be/qol/downloads/reference_values_manual2008.pdf,accessed Jan 14, 2009) European Organization for Research and Treatment of Cancer—Quality of Life Department: Brussels, Belgium, 2008.

    Google Scholar 

  17. Bush NE, Haberman M, Donaldson G, Sullivan KM . Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation. Soc Sci Med 1995; 40: 479–490.

    Article  CAS  PubMed  Google Scholar 

  18. Molassiotis A, Morris PJ . Quality of life in patients with chronic myeloid leukemia after unrelated donor bone marrow transplantation. Cancer Nurs 1999; 22: 340–349.

    Article  CAS  PubMed  Google Scholar 

  19. Zittoun R, Achard S, Ruszniewski M . Assessment of quality of life during intensive chemotherapy or bone marrow transplantation. Psychooncology 1999; 8: 64–73.

    Article  CAS  PubMed  Google Scholar 

  20. Watson M, Buck G, Wheatley K, Homewood JR, Goldstone AH, Rees JKH et al. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial. Eur J Cancer 2004; 40: 971–978.

    Article  CAS  PubMed  Google Scholar 

  21. Wettergren L, Langius A, Björkholm M, Björvell H . Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation—a prospective study. Bone Marrow Transplant 1997; 20: 497–502.

    Article  CAS  PubMed  Google Scholar 

  22. Olivieri A, Capelli D, Montanari M, Brunori M, Massidda D, Poloni A et al. Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience. Bone Marrow Transplant 2001; 27: 1189–1195.

    Article  CAS  PubMed  Google Scholar 

  23. Gulbrandsen N, Hjermstad MJ, Wisløff F . Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. Eur J Haematol 2004; 72: 172–180.

    Article  PubMed  Google Scholar 

  24. Poppelreuter M, Weis J, Mumm A, Orth HB, Bartsch HH . Rehabilitation of therapy-related cognitive deficits in patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 79–90.

    Article  CAS  PubMed  Google Scholar 

  25. Harder H, Duivenvoorden HJ, van Gool AR, Cornelissen JJ, van den Bent MJ . Neurocognitive functions and quality of life in haematological patients receiving haematopoietic stem cell grafts: a one-year follow-up pilot study. J Clin Exp Neuropsychol 2006; 28: 283–293.

    Article  PubMed  Google Scholar 

  26. Hjermstad MJ, Evensen SA, Kvaloy SO, Fayers PM, Kaasa S . Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. J Clin Oncol 1999; 17: 706–718.

    Article  CAS  PubMed  Google Scholar 

  27. Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation. Bone Marrow Transplant 2004; 34: 257–266.

    Article  CAS  PubMed  Google Scholar 

  28. Hacker ED, Ferrans CE . Quality of life immediately after peripheral blood stem cell transplantation. Cancer Nurs 2003; 26: 312–322.

    Article  PubMed  Google Scholar 

  29. Kamm M . Veränderungen von Indikatoren der Lebensqualität’ nach Hochdosis-Chemotherapie (Dissertation; accessible online: http://webdoc.sub.gwdg.de/diss/2004/kamm/kamm.pdf ) Universität Göttingen: Göttingen, 2004.

    Google Scholar 

  30. Frick E, Borasio GD, Zehentner H, Fischer N, Bumeder I . Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation. Psychooncology 2004; 13: 116–124.

    Article  CAS  PubMed  Google Scholar 

  31. Frick E, Rieg-Appleson C, Tyroller M, Bumeder I . Social support, affectivity, and the quality of life of patients and their support-givers prior to stem cell transplantation. J Psychosoc Oncol 2005; 23: 15–34.

    Article  PubMed  Google Scholar 

  32. Baumann FT . Auswirkungen von Bewegungstherapie auf die physische und psychische Verfassung von Patienten im Rahmen einer hämatopoetischen Stammzelltransplantation (Dissertation). Institut für Rehabilitation und Behindertensport der Deutschen Sporthochschule Köln: Köln, 2005.

    Google Scholar 

  33. Frick E, Ramm G, Bumeder I, Schulz-Kindermann F, Tyroller M, Fischer N et al. Social support and quality of life of patients prior to stem cell or bone marrow transplantation. Br J Health Psychol 2006; 11: 451–462.

    Article  PubMed  Google Scholar 

  34. Hacker ED, Ferrans C, Verlen E, Ravandi F, van Besien K, Gelms J et al. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 2006; 33: 614–624.

    Article  Google Scholar 

  35. Schulz-Kindermann F, Mehnert A, Scherwath A, Schirmer L, Schleimer B, Zander AR et al. Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies. Bone Marrow Transplant 2007; 39: 789–799.

    Article  CAS  PubMed  Google Scholar 

  36. Grulke N . Psychosoziale Prädiktoren. Eine Studie zur Überlebenszeit von Patienten unter allogener hämatopoietischer Stammzelltransplantation. Ulmer Textbank: Ulm, 2007.

    Google Scholar 

  37. Jarden M, Baadsgaard MT, Hovgaard DJ, Boesen E, Adamsen L . A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant 2009; 43: 725–737.

    Article  CAS  PubMed  Google Scholar 

  38. Rischer J, Scherwath A, Zander AR, Koch U, Schulz-Kindermann F . Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation. Bone Marrow Transplant 2009; 44: 121–128.

    Article  CAS  PubMed  Google Scholar 

  39. Wettergren L, Sprangers M, Björkholm M, Langius-Eklöf A . Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument. Psychooncology 2008; 17: 338–346.

    Article  CAS  PubMed  Google Scholar 

  40. Brandberg Y, Michelson H, Nilsson B, Bolund C, Erikstein B, Hietanen P et al. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401. J Clin Oncol 2003; 21: 3659–3664.

    Article  CAS  PubMed  Google Scholar 

  41. Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P . Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002; 30: 785–792.

    Article  CAS  PubMed  Google Scholar 

  42. Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW et al. Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment. Ann Hematol 1998; 77: 27–32.

    Article  CAS  PubMed  Google Scholar 

  43. Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM . Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant 2000; 6: 576–591.

    Article  CAS  PubMed  Google Scholar 

  44. Uyl-de Groot CA, Buijt I, Gloudemans IJM, Ossenkoppele GJ, Berg HP, Huijgens PC . Health related quality of life in patients with multiple myeloma undergoing a double transplantation. Eur J Haematol 2005; 74: 136–143.

    Article  CAS  PubMed  Google Scholar 

  45. Caocci G, Pisu S, Argiolu F, Giardini C, Locatelli F, Vacca A et al. Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues. Bone Marrow Transplant 2006; 37: 165–169.

    Article  CAS  PubMed  Google Scholar 

  46. Gulbrandsen N, Wisløff F, Nord E, Lenhoff S, Hjorth M, Westin J et al. Cost–utility analysis of high-dose melphalan with autologous blood stem cell support vs melphalan plus prednisone in patients younger than 60 years with multiple myeloma. Eur J Haematol 2001; 66: 328–336.

    Article  CAS  PubMed  Google Scholar 

  47. Hensel M, Egerer G, Schneeweiss A, Goldschmidt H, Ho AD . Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann Oncol 2002; 13: 209–217.

    Article  CAS  PubMed  Google Scholar 

  48. Harder H, Cornelissen JJ, Van-Gool AR, Duivenvoorden HJ, Eijkenboom WMH, Van den Bent MJ . Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer 2002; 95: 183–192.

    Article  PubMed  Google Scholar 

  49. Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant 1997; 20: 307–315.

    Article  CAS  PubMed  Google Scholar 

  50. Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F et al. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns 2007; 66: 108–118.

    Article  PubMed  Google Scholar 

  51. Hsu C, Wang J-D, Hwang J-S, Tien H-F, Chang S-M, Cheng A-L et al. Survival-weighted health profile for long-term survivors of acute myelogenous leukemia. Qual Life Res 2003; 12: 503–517.

    Article  PubMed  Google Scholar 

  52. Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 619–626.

    Article  CAS  PubMed  Google Scholar 

  53. Messerer D, Engel J, Hasford J, Schaich M, Ehninger G, Sauerland C et al. Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica 2008; 93: 826–833.

    Article  PubMed  Google Scholar 

  54. Hayden PJ, Keogh F, Conghaile MN, Carroll M, Crowley M, Fitzsimon N et al. A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukemia in first chronic phase. Bone Marrow Transplant 2004; 34: 545–556.

    Article  CAS  PubMed  Google Scholar 

  55. Gielissen MFM, Schattenberg AVM, Verhagen CAHHVM, Rinkes MJ, Bremmers MEJ, Bleijenberg G . Experience of severe fatigue in long-term survivors of stem cell transplantation. Bone Marrow Transplant 2007; 39: 595–603.

    Article  CAS  PubMed  Google Scholar 

  56. Kopp M, Holzner B, Meraner V, Sperner-Unterweger B, Kemmler G, Nguyen-Van-Tam DP et al. Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls. Eur J Haematol 2005; 74: 304–308.

    Article  PubMed  Google Scholar 

  57. Loberiza FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC et al. Associations of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 2002; 20: 2118–2126.

    Article  PubMed  Google Scholar 

  58. Grulke N, Larbig W, Kächele H, Bailer H . Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation. Psychooncology 2008; 17: 480–487.

    Article  PubMed  Google Scholar 

  59. van Belle G . Statistical Rules of Thumb. Wiley: New York, 2002.

    Google Scholar 

  60. Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 2004; 104: 1898–1906.

    Article  CAS  PubMed  Google Scholar 

  61. Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers MED et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. J Am Med Assoc 2004; 291: 2335–2343.

    Article  CAS  Google Scholar 

  62. Osoba D, Rodrigues G, Myles J, Zee B, Pater J . Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139–144.

    Article  CAS  PubMed  Google Scholar 

  63. King MT . The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996; 5: 555–567.

    Article  CAS  PubMed  Google Scholar 

  64. Cohen J . Statistical Power Analysis for the Behavioral Sciences. 2 edn. Lawrence Erlbaum Associates: Hillsdale, New Jersey, 1988.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Luisenklinik—Zentrum für Verhaltensmedizin, Bad Dürrheim, Germany

    N Grulke & H Bailer

  2. Department of Psychosomatic Medicine and Psychotherapy, Ulm University, Ulm, Germany

    N Grulke & H Bailer

  3. Schussental-Klinik gGmbH, Aulendorf, Germany

    C Albani

  4. Department of Medical Psychology, Leipzig University, Leipzig, Germany

    C Albani

Authors
  1. N Grulke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Albani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Bailer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H Bailer.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grulke, N., Albani, C. & Bailer, H. Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30. Bone Marrow Transplant 47, 473–482 (2012). https://doi.org/10.1038/bmt.2011.107

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.107

Keywords

This article is cited by

Search

Advanced search

Quick links